GlassScriptPhysician profile
Tarek Helmy
NPI 1851306641
$45,540.16
in general payments reported to CMS, 2019-2025
34 companies · $947 in 2025
The $947 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,189 · 2020: $1,288 · 2021: $1,048 · 2022: $8,542 · 2023: $14K · 2024: $15K · 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $6,226 · Food and Beverage: $4,935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,312.50 |
| Travel and Lodging | $6,225.66 |
| Food and Beverage | $4,935.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $26,993.04 | 2021-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $5,012.29 | 2019-2024 | Wolverine Coronary Cutting Balloon, Avvigo Guidance System, Rotapro |
| Abiomed | $3,787.39 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $2,377.85 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Corindus INC. | $1,839.94 | 2019 | |
| Abbott Laboratories | $1,821.98 | 2019-2024 | Mitraclip, Coroflow |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,004.82 | 2020-2025 | Lifevest |
| Medtronic Vascular, INC. | $467.53 | 2019 | |
| Penumbra, INC. | $413.54 | 2019-2024 | Indigo System |
| Pfizer INC. | $257.40 | 2020-2022 | |
| Cardiovascular Systems INC. | $204.51 | 2019-2021 | |
| Cardiva Medical, INC. | $183.13 | 2024-2025 | Savvywire, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Impulse Dynamics (USA) INC. | $168.56 | 2025 | Optimizer |
| Shockwave Medical, INC | $133.13 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lundbeck LLC | $113.11 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $104.98 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $101.56 | 2021-2023 | Camzyos |
| Merck Sharp & Dohme LLC | $93.60 | 2023 | Verquvo |
| Amgen INC. | $54.21 | 2019 | |
| Janssen Pharmaceuticals, INC | $45.61 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $45.29 | 2024-2025 | Assure Wcd |
| Heartflow, INC. | $39.91 | 2022 | |
| Siemens Medical Solutions USA, INC. | $35.38 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.56 | 2021-2023 | Jardiance |
| Daiichi Sankyo INC. | $28.79 | 2023 | Injectafer |
| Astrazeneca Pharmaceuticals LP | $26.44 | 2020-2023 | Farxiga |
| Zoll Circulation INC | $25.11 | 2025 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Alexion Pharmaceuticals, INC. | $22.34 | 2025 | Ultomiris |
| Novo Nordisk INC | $21.74 | 2024 | Ozempic, Rybelsus |
| Lexicon Pharmaceuticals, INC. | $20.65 | 2023 | Inpefa |
| Takeda Pharmaceuticals U.S.A., INC. | $18.57 | 2025 | Entyvio |
| Scpharmaceuticals INC. | $17.87 | 2023 | |
| Lantheus Medical Imaging, INC. | $14.43 | 2019 | |
| Bard Peripheral Vascular, INC. | $13.90 | 2024 | Lutonix Drug Coated Balloon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarek Helmy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.